Breaking News Instant updates and real-time market news.

FOX

21st Century Fox

$27.12

-0.29 (-1.06%)

, FOXA

21st Century Fox

$27.45

-0.29 (-1.05%)

11:48
06/19/17
06/19
11:48
06/19/17
11:48

fuboTV closes $55M Series C round; 21st Century Fox, Sky participate

fuboTV, a sports-first streaming TV service, announced it raised an additional $55M. The Series C round was led by Europe and New York-based VC fund Northzone, which will take a board position at the company. Also participating in the round are 21st Century Fox (FOX, FOXA) and Sky (SKYAY) - both previously part of fuboTV's Series B round - and Scripps Networks Interactive (SNI). The total investment raised to date by fuboTV is now more than $75M.

FOX

21st Century Fox

$27.12

-0.29 (-1.06%)

FOXA

21st Century Fox

$27.45

-0.29 (-1.05%)

SKYAY

Sky

$49.24

0.14 (0.29%)

SNI

Scripps Networks

$67.35

-0.31 (-0.46%)

FOX 21st Century Fox
$27.12

-0.29 (-1.06%)

01/03/17
01/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore ISI analyst Vijay Jayant upgraded Disney (DIS) to Buy from Hold, named it Top Pick for 2017, and raised its price target to $120 from $103. Jayan believes Disney's valuation reflects well-understood short-term growth challenges at ESPN and tough Studio and Consumer Products growth comparisons. 2. Wells Fargo analyst Marci Ryvicker upgraded 21st Century Fox (FOXA) to Outperform saying the market could be surprised by the synergies from the Sky deal. The analyst also believes concerns over the Regional Sports Networks being excluded from the streaming bundles are overblown. She expects consensus estimates to go up not down and raised her price target range for the shares to $33-$35 from $28-$30. 3. Citi analyst Michael Rollins upgraded Verizon (VZ) Communications to Buy from Neutral and raised his price target for the shares to $60 from $55. 4. Evercore ISI upgraded PACCAR (PCAR) to Buy from Hold and raised its price target to $77 from $59, with analyst David Raso saying he is incrementally bullish on the Industrials and Machinery sector since his pre-US election sector upgrade. 5. Credit Suisse upgraded Xerox (XRX) to Outperform from Neutral. Analyst Kulbinder Garcha changed his rating following the Conduent (CNDT) spin-off citing a more focused printing business, potential upside to cost savings, and management's realistic vision and a well laid out long-term strategy to offset end market decline. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/04/17
RSBL
04/04/17
INITIATION
Target $33
RSBL
Neutral
21st Century Fox initiated with a Neutral at Rosenblatt
Rosenblatt started 21st Century Fox with a Neutral rating and $33 price target.
04/04/17
PIVT
04/04/17
NO CHANGE
Target $36
PIVT
Buy
Boycotts of O'Reilly Factor likely manageable for now, says Pivotal Research
Pivotal Research analyst Brian Wieser said advertiser boycotts of O'Reilly Factor are likely manageable and only slightly negative at this time, but added that a more significant concern is the potential for this to impact Ofcom's "fit and proper" test related to Fox's (FOXA) proposed takeover of Sky (SKYAY). Wieser, who views the Sky acquisition as a favorable strategic combination, would sees the U.K. regulator not allowing the transaction to proceed as a negative. However, he keeps a Buy rating and $36 price target on Fox shares.
04/26/17
FBCO
04/26/17
NO CHANGE
Target $37
FBCO
Outperform
Hulu stake could be for sale this year, says Credit Suisse
Credit Suisse analyst Omar Sheikh notes that Comcast (CMCSA; CMCSK) will be free to sell its 30% stake in Hulu from the end of 2017. The analyst believes there is a $100B domestic revenue opportunity for targeted TV advertising long-term, which vertically integrated networks/distributors will be in a strong position to exploit. Therefore, Sheikh argues that it would make sense for 21st Century Fox (FOX; FOXA) to acquire Comcast's stake in Hulu, if it becomes available, subject to valuation and appropriate programming supply agreements. He reiterates an Outperform rating and $37 price target on 21st Century Fox's shares.
FOXA 21st Century Fox
$27.45

-0.29 (-1.05%)

05/12/17
FBCO
05/12/17
NO CHANGE
Target $37
FBCO
Outperform
21st Century Fox 'highly attractive' long-term growth stock, says Credit Suisse
Credit Suisse analyst Omar Sheikh reiterates his bullish view on 21st Century Fox following better than expected Q3 earnings. With some of the most attractive studio/network assets in the peer group, stakes in over-the-top distribution platforms globally, and an industry-leading position in the emerging targeted linear advertising market with Open AP, the analyst continues to believe 21st Century Fox is a "highly attractive" long-term growth stock trading at a compelling valuation. He reiterates an Outperform rating and $37 price target on the shares.
SKYAY Sky
$49.24

0.14 (0.29%)

12/14/16
BMUR
12/14/16
UPGRADE
Target $33
BMUR
Buy
21st Century Fox upgraded to Buy from Hold at Brean Capital
Brean Capital analyst Alan Gould upgraded 21st Century Fox (FOX) to Buy saying the selloff since the Sky (SKYAY) announcement is overdone. Fox stock "has significantly" underperformed the market over the past six months as estimates have come down, Gould tells investors in a research note. The analyst likes the prospects of a potential Fox/Sky merger and finds Fox shares inexpensive. He has a $33 price target for the stock.
12/22/16
FBCO
12/22/16
DOWNGRADE
FBCO
Neutral
Sky downgraded to Neutral from Outperform at Credit Suisse
04/26/17
JEFF
04/26/17
UPGRADE
JEFF
Buy
Sky upgraded to Buy from Hold at Jefferies
Price target GBP 1,200p.
SNI Scripps Networks
$67.35

-0.31 (-0.46%)

02/22/17
NEED
02/22/17
NO CHANGE
Target $90
NEED
Buy
Scripps Networks price target raised to $90 from $82 at Needham
Needham analyst Laura Martin raised her price target for Scripps Networks to $90 from $82 following quarterly results. She reiterates a Buy rating on the shares.
05/05/17
JPMS
05/05/17
UPGRADE
Target $83
JPMS
Overweight
Scripps Networks upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alexia Quadrani upgraded Scripps Networks Interactive to Overweight citing the 10% pullback in the shares over the past month. The analyst notes Scripps offered "strong commentary" on ad revenue and is now included in Hulu Live. She keeps an $83 price target for the shares.
05/05/17
05/05/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Zynga (ZNGA) upgraded to Neutral from Underperform at BofA/Merrill with analyst Justin Post citing stronger engagement that is driving bookings growth. 2. Hess Corp. (HES) upgraded to Outperform from Market Perform at Wells Fargo citing what it sees as Hess' "growth potential, strong operating cost performance, balance sheet strength, exploration upside and current discounted valuation." Wells expects the company to grow at a compound annual rate of 4.9% through 2019. 3. CF Industries (CF) upgraded to Buy from Neutral at UBS with analyst John Roberts saying the stock is a top pick on the eventual agricultural recovery. Limited nitrogen capacity coming post 2017 and the dividend yield position the stock for upside, Roberts tells investors in a research note. The analyst keeps a $33 price target for the shares. 4. TreeHouse (THS) upgraded to Overweight from Equal Weight at Stephens. 5. Scripps Networks (SNI) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani citing the 10% pullback in the shares over the past month. The analyst notes Scripps offered "strong commentary" on ad revenue and is now included in Hulu Live. She keeps an $83 price target for the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/19/17
RBCM
05/19/17
NO CHANGE
RBCM
Discovery likely to make deal, says RBC Capital
As the situation deteriorates for media companies due to accelerating cord cutting and weak ad trends, RBC Capital analyst Steven Cahall thinks that companies in the sector will look to consolidate. He thinks that Discovery (DISCA) will likely look to combine with either Lionsgate (LGF.A,LGF.B) or Charter (CHTR) and could look to combine with Scripps Networks (SNI).

TODAY'S FREE FLY STORIES

TGS

Transportadora de Gas del Sur SA

$17.48

0.07 (0.40%)

07:49
09/19/17
09/19
07:49
09/19/17
07:49
Initiation
Transportadora de Gas del Sur SA initiated  »

Transportadora de Gas del…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAM

Pampa Energia S.A.

$60.93

0.2 (0.33%)

07:48
09/19/17
09/19
07:48
09/19/17
07:48
Initiation
Pampa Energia S.A. initiated  »

Pampa Energia S.A. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Breaking Hot Stocks news story on Progress Software »

Progress:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRGS

Progress Software

$37.49

0.18 (0.48%)

07:47
09/19/17
09/19
07:47
09/19/17
07:47
Hot Stocks
Progress Software 'values' Praesidium's ideas, welcomes input from investors »

In response to a letter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

, AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Hot Stocks
Jacobs Engineering selected by Aerie Pharmaceuticals as engineering contractor »

Jacobs Engineering Group…

JEC

Jacobs Engineering

$56.76

0.81 (1.45%)

AERI

Aerie Pharmaceuticals

$60.10

1.8 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

  • 28

    Feb

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

, AXAHY

AXA

$29.47

0.13 (0.44%)

07:46
09/19/17
09/19
07:46
09/19/17
07:46
Periodicals
BNP weighing tie-up of money-management division with Axa unit, Bloomberg says »

BNP Paribas (BNPQY),…

BNPQY

BNP Paribas

$39.68

0.19 (0.48%)

AXAHY

AXA

$29.47

0.13 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHFC

Chemical Financial

$49.32

0.71 (1.46%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Downgrade
Chemical Financial rating change  »

Chemical Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSII

Quality Systems

$15.71

-0.14 (-0.88%)

07:45
09/19/17
09/19
07:45
09/19/17
07:45
Initiation
Quality Systems initiated  »

Quality Systems initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:45
09/19/17
09/19
07:45
09/19/17
07:45
General news
N.Y. FX Outlook »

N.Y. FX Outlook: Risk-on…

HOLI

Hollysys

$20.77

0.42 (2.06%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Conference/Events
Hollysys management to meet with Deutsche Bank »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 16

    Oct

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

, AMGN

Amgen

$186.47

-1 (-0.53%)

07:44
09/19/17
09/19
07:44
09/19/17
07:44
Hot Stocks
Cytokinetics doses first patient in Japan in GALACTIC-HF Phase 3 trial »

Cytokinetics announced…

CYTK

Cytokinetics

$14.25

0.1 (0.71%)

AMGN

Amgen

$186.47

-1 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Dec

  • 03

    Feb

  • 30

    Apr

  • 17

    May

KORS

Michael Kors

$44.65

-0.27 (-0.60%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Technical Analysis
Technical View: Michael Kors moves higher, analyst action »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Periodicals
Intel Capital invested over $1B in AI-focused companies, TechCrunch says »

Intel has invested more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 05

    Oct

PDCO

Patterson Companies

$37.94

-0.59 (-1.53%)

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Initiation
Patterson Companies initiated  »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$179.98

3.28 (1.86%)

, BSTI

BEST Inc

07:43
09/19/17
09/19
07:43
09/19/17
07:43
Syndicate
BEST Inc cuts size of proposed IPO following 'tepid' response, Reuters reports »

Best Inc (BSTI), a…

BABA

Alibaba

$179.98

3.28 (1.86%)

BSTI

BEST Inc

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

FOLD

Amicus

$13.67

-0.21 (-1.51%)

07:42
09/19/17
09/19
07:42
09/19/17
07:42
Hot Stocks
Amicus granted FDA Fast Track Designation for migalastat »

Amicus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RAD

Rite Aid

$2.73

0.1 (3.80%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Initiation
Rite Aid initiated  »

Rite Aid initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

MDGL

Madrigal Pharmaceuticals

$19.80

0.99 (5.26%)

07:41
09/19/17
09/19
07:41
09/19/17
07:41
Hot Stocks
Madrigal Pharmaceuticals announces positive outcome from pre-planned DSMB review »

Madrigal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDSO

Medidata

$75.85

-0.01 (-0.01%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Initiation
Medidata initiated  »

Medidata initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.